Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Cisplatin + 5-FU in Advanced Gastric Cancer
NCT00811447Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2008
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel in gastric cancer (GC) (2 arms), sponsored by Sanofi. Primary endpoint: Time to Progression. Started Nov 2008; status: completed.
02
Drugs
docetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00811447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811447.